You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

Details for New Drug Application (NDA): 208912


✉ Email this page to a colleague

« Back to Dashboard


NDA 208912 describes DEXYCU KIT, which is a drug marketed by Eyepoint Pharms and is included in one NDA. It is available from one supplier. There are five patents protecting this drug. Additional details are available on the DEXYCU KIT profile page.

The generic ingredient in DEXYCU KIT is dexamethasone. There are thirty-nine drug master file entries for this compound. Forty-three suppliers are listed for this compound. Additional details are available on the dexamethasone profile page.
Summary for 208912
Tradename:DEXYCU KIT
Applicant:Eyepoint Pharms
Ingredient:dexamethasone
Patents:5
Pharmacology for NDA: 208912
Medical Subject Heading (MeSH) Categories for 208912
Suppliers and Packaging for NDA: 208912
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
DEXYCU KIT dexamethasone SUSPENSION;INTRAOCULAR 208912 NDA EyePoint Pharmaceuticals US, Inc 71879-001 71879-001-01 1 VIAL, GLASS in 1 CARTON (71879-001-01) / .5 mL in 1 VIAL, GLASS

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:SUSPENSION;INTRAOCULARStrength9%
Approval Date:Feb 9, 2018TE:RLD:Yes
Patent:⤷  Sign UpPatent Expiration:Jun 22, 2034Product Flag?Substance Flag?Delist Request?
Patented Use:TREATMENT OF POSTOPERATIVE INFLAMMATION
Patent:⤷  Sign UpPatent Expiration:May 23, 2034Product Flag?Substance Flag?Delist Request?
Patented Use:TREATMENT OF POSTOPERATIVE INFLAMMATION
Patent:⤷  Sign UpPatent Expiration:May 23, 2034Product Flag?YSubstance Flag?Delist Request?

Expired US Patents for NDA 208912

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Eyepoint Pharms DEXYCU KIT dexamethasone SUSPENSION;INTRAOCULAR 208912-001 Feb 9, 2018 ⤷  Sign Up ⤷  Sign Up
Eyepoint Pharms DEXYCU KIT dexamethasone SUSPENSION;INTRAOCULAR 208912-001 Feb 9, 2018 ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.